Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.

Market Analysis and Insights: Global Molecular Diagnosis and Therapy Market

The global Molecular Diagnosis and Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Molecular Diagnosis and Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Molecular Diagnosis and Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Diagnosis and Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Diagnosis and Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Molecular Diagnosis and Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Molecular Diagnosis and Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Molecular Diagnosis and Therapy Market Report

Report Metric	Details
Report Name	Molecular Diagnosis and Therapy Market
CAGR	5%
Segment by Type	PCR DNA Sequencing NGS
Segment by Application	Diagnostic Laboratories Research & Academic Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Diagnosis and Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnosis and Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnosis and Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Molecular Diagnosis and Therapy Market report?

Ans: The main players in the Molecular Diagnosis and Therapy Market are Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific

What are the Application segmentation covered in the Molecular Diagnosis and Therapy Market report?

Ans: The Applications covered in the Molecular Diagnosis and Therapy Market report are Diagnostic Laboratories, Research & Academic Laboratories

What are the Type segmentation covered in the Molecular Diagnosis and Therapy Market report?

Ans: The Types covered in the Molecular Diagnosis and Therapy Market report are PCR, DNA Sequencing, NGS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 PCR

1.2.3 DNA Sequencing

1.2.4 NGS

1.3 Market by Application

1.3.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Diagnostic Laboratories

1.3.3 Research & Academic Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnosis and Therapy Market Perspective (2019-2030)

2.2 Global Molecular Diagnosis and Therapy Growth Trends by Region

2.2.1 Molecular Diagnosis and Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Molecular Diagnosis and Therapy Historic Market Size by Region (2019-2024)

2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Region (2025-2030)

2.3 Molecular Diagnosis and Therapy Market Dynamics

2.3.1 Molecular Diagnosis and Therapy Industry Trends

2.3.2 Molecular Diagnosis and Therapy Market Drivers

2.3.3 Molecular Diagnosis and Therapy Market Challenges

2.3.4 Molecular Diagnosis and Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Molecular Diagnosis and Therapy by Players

3.1.1 Global Molecular Diagnosis and Therapy Revenue by Players (2019-2024)

3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Molecular Diagnosis and Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio

3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2023

3.5 Global Key Players of Molecular Diagnosis and Therapy Head office and Area Served

3.6 Global Key Players of Molecular Diagnosis and Therapy, Product and Application

3.7 Global Key Players of Molecular Diagnosis and Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnosis and Therapy Breakdown Data by Type

4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2019-2024)

4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2025-2030)

5 Molecular Diagnosis and Therapy Breakdown Data by Application

5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2019-2024)

5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Molecular Diagnosis and Therapy Market Size (2019-2030)

6.2 North America Molecular Diagnosis and Therapy Market Size by Type

6.2.1 North America Molecular Diagnosis and Therapy Market Size by Type (2019-2024)

6.2.2 North America Molecular Diagnosis and Therapy Market Size by Type (2025-2030)

6.2.3 North America Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

6.3 North America Molecular Diagnosis and Therapy Market Size by Application

6.3.1 North America Molecular Diagnosis and Therapy Market Size by Application (2019-2024)

6.3.2 North America Molecular Diagnosis and Therapy Market Size by Application (2025-2030)

6.3.3 North America Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

6.4 North America Molecular Diagnosis and Therapy Market Size by Country

6.4.1 North America Molecular Diagnosis and Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Molecular Diagnosis and Therapy Market Size by Country (2019-2024)

6.4.3 North America Molecular Diagnosis and Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Molecular Diagnosis and Therapy Market Size (2019-2030)

7.2 Europe Molecular Diagnosis and Therapy Market Size by Type

7.2.1 Europe Molecular Diagnosis and Therapy Market Size by Type (2019-2024)

7.2.2 Europe Molecular Diagnosis and Therapy Market Size by Type (2025-2030)

7.2.3 Europe Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

7.3 Europe Molecular Diagnosis and Therapy Market Size by Application

7.3.1 Europe Molecular Diagnosis and Therapy Market Size by Application (2019-2024)

7.3.2 Europe Molecular Diagnosis and Therapy Market Size by Application (2025-2030)

7.3.3 Europe Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

7.4 Europe Molecular Diagnosis and Therapy Market Size by Country

7.4.1 Europe Molecular Diagnosis and Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Molecular Diagnosis and Therapy Market Size by Country (2019-2024)

7.4.3 Europe Molecular Diagnosis and Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Molecular Diagnosis and Therapy Market Size (2019-2030)

8.2 China Molecular Diagnosis and Therapy Market Size by Type

8.2.1 China Molecular Diagnosis and Therapy Market Size by Type (2019-2024)

8.2.2 China Molecular Diagnosis and Therapy Market Size by Type (2025-2030)

8.2.3 China Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

8.3 China Molecular Diagnosis and Therapy Market Size by Application

8.3.1 China Molecular Diagnosis and Therapy Market Size by Application (2019-2024)

8.3.2 China Molecular Diagnosis and Therapy Market Size by Application (2025-2030)

8.3.3 China Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Molecular Diagnosis and Therapy Market Size (2019-2030)

9.2 Asia Molecular Diagnosis and Therapy Market Size by Type

9.2.1 Asia Molecular Diagnosis and Therapy Market Size by Type (2019-2024)

9.2.2 Asia Molecular Diagnosis and Therapy Market Size by Type (2025-2030)

9.2.3 Asia Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

9.3 Asia Molecular Diagnosis and Therapy Market Size by Application

9.3.1 Asia Molecular Diagnosis and Therapy Market Size by Application (2019-2024)

9.3.2 Asia Molecular Diagnosis and Therapy Market Size by Application (2025-2030)

9.3.3 Asia Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

9.4 Asia Molecular Diagnosis and Therapy Market Size by Region

9.4.1 Asia Molecular Diagnosis and Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Molecular Diagnosis and Therapy Market Size by Region (2019-2024)

9.4.3 Asia Molecular Diagnosis and Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction

11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.1.5 Abbott Laboratories Recent Developments

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Details

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction

11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.2.5 Agilent Technologies Recent Developments

11.3 Becton, Dickinson and Company

11.3.1 Becton, Dickinson and Company Company Details

11.3.2 Becton, Dickinson and Company Business Overview

11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction

11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.3.5 Becton, Dickinson and Company Recent Developments

11.4 Biomérieux Sa

11.4.1 Biomérieux Sa Company Details

11.4.2 Biomérieux Sa Business Overview

11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction

11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.4.5 Biomérieux Sa Recent Developments

11.5 Danaher Corporation

11.5.1 Danaher Corporation Company Details

11.5.2 Danaher Corporation Business Overview

11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction

11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.5.5 Danaher Corporation Recent Developments

11.6 Diasorin

11.6.1 Diasorin Company Details

11.6.2 Diasorin Business Overview

11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction

11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.6.5 Diasorin Recent Developments

11.7 Grifols

11.7.1 Grifols Company Details

11.7.2 Grifols Business Overview

11.7.3 Grifols Molecular Diagnosis and Therapy Introduction

11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.7.5 Grifols Recent Developments

11.8 Hologic

11.8.1 Hologic Company Details

11.8.2 Hologic Business Overview

11.8.3 Hologic Molecular Diagnosis and Therapy Introduction

11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.8.5 Hologic Recent Developments

11.9 Illumina

11.9.1 Illumina Company Details

11.9.2 Illumina Business Overview

11.9.3 Illumina Molecular Diagnosis and Therapy Introduction

11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.9.5 Illumina Recent Developments

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction

11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.10.5 Qiagen Recent Developments

11.11 Roche Diagnostics

11.11.1 Roche Diagnostics Company Details

11.11.2 Roche Diagnostics Business Overview

11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction

11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.11.5 Roche Diagnostics Recent Developments

11.12 Siemens AG

11.12.1 Siemens AG Company Details

11.12.2 Siemens AG Business Overview

11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction

11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.12.5 Siemens AG Recent Developments

11.13 Thermo Fisher Scientific

11.13.1 Thermo Fisher Scientific Company Details

11.13.2 Thermo Fisher Scientific Business Overview

11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction

11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2019-2024)

11.13.5 Thermo Fisher Scientific Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories

Agilent Technologies

Becton Dickinson and Company

Thermo Fisher Scientific

List of Tables

Table 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of DNA Sequencing

Table 4. Key Players of NGS

Table 5. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Molecular Diagnosis and Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Molecular Diagnosis and Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Molecular Diagnosis and Therapy Market Share by Region (2019-2024)

Table 9. Global Molecular Diagnosis and Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Molecular Diagnosis and Therapy Market Share by Region (2025-2030)

Table 11. Molecular Diagnosis and Therapy Market Trends

Table 12. Molecular Diagnosis and Therapy Market Drivers

Table 13. Molecular Diagnosis and Therapy Market Challenges

Table 14. Molecular Diagnosis and Therapy Market Restraints

Table 15. Global Molecular Diagnosis and Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Molecular Diagnosis and Therapy Revenue Share by Players (2019-2024)

Table 17. Global Top Molecular Diagnosis and Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2023)

Table 18. Global Molecular Diagnosis and Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Molecular Diagnosis and Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Molecular Diagnosis and Therapy, Headquarters and Area Served

Table 21. Global Key Players of Molecular Diagnosis and Therapy, Product and Application

Table 22. Global Key Players of Molecular Diagnosis and Therapy, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Molecular Diagnosis and Therapy Revenue Share by Application (2019-2024)

Table 30. Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Molecular Diagnosis and Therapy Revenue Share by Application (2025-2030)

Table 32. North America Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Molecular Diagnosis and Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Molecular Diagnosis and Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Molecular Diagnosis and Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Molecular Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Molecular Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Molecular Diagnosis and Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Molecular Diagnosis and Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Molecular Diagnosis and Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Molecular Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Molecular Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Molecular Diagnosis and Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Molecular Diagnosis and Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Molecular Diagnosis and Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Molecular Diagnosis and Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Molecular Diagnosis and Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Molecular Diagnosis and Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Molecular Diagnosis and Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 64. Abbott Laboratories Company Details

Table 65. Abbott Laboratories Business Overview

Table 66. Abbott Laboratories Molecular Diagnosis and Therapy Product

Table 67. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 68. Abbott Laboratories Recent Developments

Table 69. Agilent Technologies Company Details

Table 70. Agilent Technologies Business Overview

Table 71. Agilent Technologies Molecular Diagnosis and Therapy Product

Table 72. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 73. Agilent Technologies Recent Developments

Table 74. Becton, Dickinson and Company Company Details

Table 75. Becton, Dickinson and Company Business Overview

Table 76. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product

Table 77. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 78. Becton, Dickinson and Company Recent Developments

Table 79. Biomérieux Sa Company Details

Table 80. Biomérieux Sa Business Overview

Table 81. Biomérieux Sa Molecular Diagnosis and Therapy Product

Table 82. Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 83. Biomérieux Sa Recent Developments

Table 84. Danaher Corporation Company Details

Table 85. Danaher Corporation Business Overview

Table 86. Danaher Corporation Molecular Diagnosis and Therapy Product

Table 87. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 88. Danaher Corporation Recent Developments

Table 89. Diasorin Company Details

Table 90. Diasorin Business Overview

Table 91. Diasorin Molecular Diagnosis and Therapy Product

Table 92. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 93. Diasorin Recent Developments

Table 94. Grifols Company Details

Table 95. Grifols Business Overview

Table 96. Grifols Molecular Diagnosis and Therapy Product

Table 97. Grifols Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 98. Grifols Recent Developments

Table 99. Hologic Company Details

Table 100. Hologic Business Overview

Table 101. Hologic Molecular Diagnosis and Therapy Product

Table 102. Hologic Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 103. Hologic Recent Developments

Table 104. Illumina Company Details

Table 105. Illumina Business Overview

Table 106. Illumina Molecular Diagnosis and Therapy Product

Table 107. Illumina Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 108. Illumina Recent Developments

Table 109. Qiagen Company Details

Table 110. Qiagen Business Overview

Table 111. Qiagen Molecular Diagnosis and Therapy Product

Table 112. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 113. Qiagen Recent Developments

Table 114. Roche Diagnostics Company Details

Table 115. Roche Diagnostics Business Overview

Table 116. Roche Diagnostics Molecular Diagnosis and Therapy Product

Table 117. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 118. Roche Diagnostics Recent Developments

Table 119. Siemens AG Company Details

Table 120. Siemens AG Business Overview

Table 121. Siemens AG Molecular Diagnosis and Therapy Product

Table 122. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 123. Siemens AG Recent Developments

Table 124. Thermo Fisher Scientific Company Details

Table 125. Thermo Fisher Scientific Business Overview

Table 126. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product

Table 127. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2019-2024) & (US$ Million)

Table 128. Thermo Fisher Scientific Recent Developments

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Molecular Diagnosis and Therapy Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. DNA Sequencing Features

Figure 5. NGS Features

Figure 6. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Molecular Diagnosis and Therapy Market Share by Application: 2023 VS 2030

Figure 8. Diagnostic Laboratories Case Studies

Figure 9. Research & Academic Laboratories Case Studies

Figure 10. Molecular Diagnosis and Therapy Report Years Considered

Figure 11. Global Molecular Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Molecular Diagnosis and Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Molecular Diagnosis and Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Molecular Diagnosis and Therapy Market Share by Players in 2023

Figure 15. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2023

Figure 17. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

Figure 19. North America Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

Figure 20. North America Molecular Diagnosis and Therapy Market Share by Country (2019-2030)

Figure 21. United States Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Molecular Diagnosis and Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

Figure 25. Europe Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

Figure 26. Europe Molecular Diagnosis and Therapy Market Share by Country (2019-2030)

Figure 27. Germany Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Molecular Diagnosis and Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

Figure 35. China Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

Figure 36. Asia Molecular Diagnosis and Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

Figure 38. Asia Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

Figure 39. Asia Molecular Diagnosis and Therapy Market Share by Region (2019-2030)

Figure 40. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Molecular Diagnosis and Therapy Market Share by Country (2019-2030)

Figure 50. Brazil Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Molecular Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 57. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 58. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 59. Biomérieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 60. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 61. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 62. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 63. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 64. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 65. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 66. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 67. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions